Clinical trials

Disease

Country

Status

Phase

Reset

31,147 trials

2025-524080-20-00
Recruiting
A clinical trial to learn about the effects of INR731 alone or with an androgen receptor pathway inhibitor (ARPI) in men with prostate cancer
Phase 1 · Germany, Spain, France, Italy · 6 sites
Registry update: 23 Oct 2026
NCT07762833
Recruiting
Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Subjects With Moderate-to-severe Atopic Dermatitis
Phase 3 · China · 1 site
Registry update: 16 Oct 2026
NCT07824882
Recruiting
A Phase II Study of HS-20093 Injection Combined With Adebrelimab Versus HS-20093 Injection in Previously Treated Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Without Actionable Genomic Alterations
Phase 2 · China · 1 site
Registry update: 23 Oct 2026
NCT07600723
Recruiting
A Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (PAH) in India (MK-7962-037)
Phase 4 · India · 3 sites
Registry update: 4 Nov 2026
NCT07673341
Recruiting
[18F]FTT Positron Emission Tomography/Computed Tomography to Predict Treatment Response in Patients Scheduled to Receive Gemcitabine, Cisplatin, and Durvalumab for Newly Diagnosed Cholangiocarcinoma
Phase 2 · United States · 1 site
Registry update: 20 Oct 2026
NCT07910019
Recruiting
Evaluating Prostate Cancer Patient Natural Killer Cell Function Across Racial Background and Addressing Functional Disparities With Trispecific Killer Engagers
Not applicable · United States · 1 site
Registry update: 2 Nov 2026
NCT07773987
Recruiting
Immunotherapy and Nodal-Sparing Irradiation for T-Cell Induction and Unmasking of Tumor Antigenicity in the Microenvironment for Head and Neck Cancer
Phase 2 · United States · 1 site
Registry update: 19 Oct 2026
NCT07873060
Recruiting
Comparing 10 Hz rTMS and iTBS for Adolescent Depression
Not applicable · China · 1 site
Registry update: 14 Oct 2026
NCT07893392
Recruiting
Phase II Study of Primary Tumor Resection and Selective Lymph Node Dissection Followed by RT for BTC With Lymph Node Metastases
Phase 2 · China · 1 site
Registry update: 26 Oct 2026
NCT07875582
Recruiting
Diagnostic Utility of Protein Biomarkers in Pancreatic Ductal Adenocarcinoma
Not applicable · Romania · 1 site
Registry update: 19 Oct 2026
NCT07880600
Recruiting
Pre-Treatment Breast DCE-MRI AI Model to Predict Neoadjuvant Chemotherapy Benefit in Locally Advanced Triple-Negative Breast Cancer
Not applicable · China · 5 sites
Registry update: 19 Oct 2026
NCT07808827
Recruiting
A Randomized, Open-Label, Multicenter Phase III Clinical Study of JS203 Plus Chemotherapy Versus Rituximab Plus Chemotherapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Phase 3 · China · 1 site
Registry update: 14 Oct 2026
NCT07767890
Recruiting
A Study of the Safety and Effectiveness of Onasemnogene Abeparvovec (Zolgensma) Intrathecal Injection in Spinal Muscular Atrophy Patients
Not applicable · Japan · 4 sites
Registry update: 22 Oct 2026
NCT07777575
Recruiting
Resistance Training to Prevent Muscle Loss During Treatment With Tirzepatide
Phase 4 · Germany · 1 site
Registry update: 20 Oct 2026
NCT07812337
Recruiting
Evaluation of a Decision-Support Tool for Blood Biomarker Testing for Alzheimer's Disease in Primary Care
Not applicable · United States · 1 site
Registry update: 28 Oct 2026
NCT07848191
Recruiting
Rezdiffra® With Concomitant Therapies Commonly Used to Treat Comorbidities in Adults With MASH and F2-F3 Fibrosis
Phase 4 · United States · 16 sites
Registry update: 16 Oct 2026
2026-527250-39-00
Recruiting
A clinical trial of MK-3586 in healthy participants (MK-3586-001)
Phase 1 · Belgium · 1 site
Registry update: 30 Sept 2026
NCT07798947
Recruiting
A Phase II Clinical Study of SHR-7787 Injection Combined With SHR-1316 Injection in Patients With LS-SCLC
Phase 2 · China · 1 site
Registry update: 19 Oct 2026
NCT07855211
Recruiting
A Study to Learn About the Safety of BIIB147 and Its Effects in Adults With Amyotrophic Lateral Sclerosis (ALS)
Phase 1/2 · United States · 2 sites
Registry update: 26 Oct 2026
2026-526172-23-00
Recruiting
Efficacy and Safety of Once-Daily Oral ASC30 Compared with Placebo in Participants with Obesity or Overweight with Weight-Related Comorbidities
Phase 3 · Czechia, Germany, Greece, Poland · 44 sites
Registry update: 29 Oct 2026

Ordered by registry start date. Freshness and sponsorship never change the order.